Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aortic root adenosine for myocardial protection during CABG
IRCT2017013019470N51Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of adenosine in coronary arteriosclerosis, sponsored by Shiraz University of Medical Sciences. Started Aug 2017; status: completed.
02
Drugs
adenosine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT2017013019470N51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017013019470N51.